Japan’s Ministry of Health, Labour and Welfare has approved Berinert S.C. Injection 2000 — a C1-inhibitor replacement therapy designed to…
Articles by Marisa Wexler, MS
The European Patent Office has granted patent protection to Verseon covering the company’s experimental plasma kallikrein inhibitors (PKIs). Two of…
NTLA-2002, an experimental gene-editing therapy designed to prevent swelling attacks in people with hereditary angioedema (HAE), has been granted…
Protease-activated receptor 1 (PAR1), a protein involved in the regulation of blood vessel permeability or leakage, may contribute to…
Most young children with hereditary angioedema (HAE) in the open-label Phase 3 SPRING study were free of swelling attacks…
Many people with hereditary angioedema (HAE) have non-swelling symptoms, such as rash or fatigue, even when they aren’t having an acute…
An approved therapy for multiple sclerosis (MS), called Gilenya (fingolimod), was effective at treating a man who had…
A common over-the-counter painkiller induced two allergic reactions — one of them leading to angioedema, and another to skin…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
A man who had been treated with the blood pressure medication losartan for 20 years experienced sudden angioedema after…